RTS,S malaria vaccine candidate receives positive opinion from European regulators
MVI welcomes positive opinion by European regulators on GSK’s Mosquirix™ (RTS,S)
Photo credit: PATH/Evelyn Hockstein
Partnering with us
We are pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners.